Inchul You
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 11
- Ubiquitin and proteasome pathways 8
- Histone Deacetylase Inhibitors Research 2
- PI3K/AKT/mTOR signaling in cancer 1
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Nathanael S. Gray (11 shared papers)Katherine A. Donovan (8 shared papers)Eric S. Fischer (8 shared papers)Nicholas A. Eleuteri (2 shared papers)Alex Toker (2 shared papers)Emily C. Erickson (2 shared papers)Jianwei Che (3 shared papers)Jie Jiang (2 shared papers)
- Journals
- Cell chemical biology (4 papers)Journal of the American Chemical Society (2 papers)Nature Chemical Biology (1 paper)Advanced Science (1 paper)Science Signaling (1 paper)
- Partner nations
- United StatesSouth KoreaGermany
In The Last Decade
Inchul You
11 papers receiving 344 citations
Peers
Comparison fields: 5 of 42
- Hematology 62
- Oncology 129
- Molecular Biology 305
- Pulmonary and Respiratory Medicine 32
- Pathology and Forensic Medicine 17
Countries citing papers authored by Inchul You
This map shows the geographic impact of Inchul You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inchul You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inchul You more than expected).
Fields of papers citing papers by Inchul You
This network shows the impact of papers produced by Inchul You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inchul You. The network helps show where Inchul You may publish in the future.
Co-authors
The 25 scholars most cited alongside Inchul You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 103 | |
| 2 | 2021 | 96 | |
| 3 | 2022 | 51 | |
| 4 | 2023 | 30 | |
| 5 | 2023 | 20 | |
| 6 | 2024 | 19 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 8 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 4 | |
| 11 | 2024 | 4 |
About Inchul You
Inchul You is a scholar working on Molecular Biology, Oncology, Hematology, Infectious Diseases and Organic Chemistry, having authored 11 papers that have together received 351 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (8 papers), Histone Deacetylase Inhibitors Research (2 papers), Multiple Myeloma Research and Treatments (2 papers), Peptidase Inhibition and Analysis (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), HIV/AIDS drug development and treatment (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Hematology (62 citations), Oncology (129 citations), Molecular Biology (305 citations), Pulmonary and Respiratory Medicine (32 citations) and Pathology and Forensic Medicine (17 citations). Inchul You has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Nathanael S. Gray, Katherine A. Donovan, Eric S. Fischer, Nicholas A. Eleuteri, Alex Toker, Emily C. Erickson, Jianwei Che, Jie Jiang, Tinghu Zhang and Ines H. Kaltheuner. Their work appears in journals such as Cell chemical biology, Journal of the American Chemical Society, Nature Chemical Biology, Advanced Science and Science Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.